Here are five notes:
1. The ancient virus could have the potential to create gene therapies that are safer and stronger than current therapies.
2. Ancient viruses used for gene therapy have thus far been chosen from viruses that naturally circulate throughout the human population.
3. The therapies would make the viruses unrecognizable by the human body and therefore will increase the number of people who will have success with the gene therapy.
4. The intricacies of the ancient viruses make them difficult to engineer. Researchers have recreated an evolutionary timeline of the changes in the virus to combat this issue.
5. The viruses have successfully targeted the liver, muscle and retina of mice without producing toxic side effects.
More articles on quality & infection control:
Merck’s Ebola vaccine efficacious in phase 3 study: 5 key points
‘Probable’ West Nile case in Ohio — 5 notes
University of Southampton to conduct study on nurse staffing: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.